Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethality.

Watanabe S, Shimada S, Akiyama Y, Ishikawa Y, Ogura T, Ogawa K, Ono H, Mitsunori Y, Ban D, Kudo A, Yamaoka S, Tanabe M, Tanaka S
Int J Cancer. 2018 Dec 17. doi: 10.1002/ijc.32072. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.